Cargando…

Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)

BACKGROUND: We aimed to test the hypothesis that the correlation of the changes in the blood Androstenedione (A(4)) levels to the number of selected follicles during ovulation induction with low-dose recombinant human follicle stimulating hormone (rhFSH) is as strong as the correlation to changes in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozyurek, Eser Sefik, Yoldemir, Tevfik, Artar, Gokhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427586/ https://www.ncbi.nlm.nih.gov/pubmed/28494798 http://dx.doi.org/10.1186/s13048-017-0330-7

Ejemplares similares

Calcium alginate microencapsulation of ovarian follicles impacts FSH delivery and follicle morphology
por: Heise, Matthew, et al.
Publicado: (2005)

FSH Requirements for Follicle Growth During Controlled Ovarian Stimulation
por: Abbara, Ali, et al.
Publicado: (2019)

Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only
por: Tayyar, Ahter Tanay, et al.
Publicado: (2018)

OR19-04 Hypoglycosylated FSH Enhances Ovarian Follicle Development and Gamete Quality
por: Converse, Aubrey, et al.
Publicado: (2023)

Long-acting recombinant human follicle-stimulating hormone (SAFA-FSH) enhances spermatogenesis
por: Kim, Daham, et al.
Publicado: (2023)

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
por: O'Reilly, Michael W., et al.
Publicado: (2014)

Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis
por: Lehert, Philippe, et al.
Publicado: (2014)

Metformin Inhibits Follicle-Stimulating Hormone (FSH) Action in Human Granulosa Cells: Relevance to Polycystic Ovary Syndrome
por: Rice, Suman, et al.
Publicado: (2013)

FSH prevents depletion of the resting follicle pool by promoting follicular number and morphology in fresh and cryopreserved primate ovarian tissues following xenografting
por: von Schönfeldt, Viktoria, et al.
Publicado: (2012)

Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype
por: Lerchbaum, Elisabeth, et al.
Publicado: (2014)

Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women
por: Saadia, Zaheera
Publicado: (2020)

The role of FSH and TGF-β superfamily in follicle atresia
por: Chu, Yu-Lan, et al.
Publicado: (2018)

Characterisation of Population Pharmacokinetics and Endogenous Follicle-Stimulating Hormone (FSH) Levels After Multiple Dosing of a Recombinant Human FSH (FE 999049) in Healthy Women
por: Rose, Trine Høyer, et al.
Publicado: (2016)

Body mass index and basal androstenedione are independent risk factors for miscarriage in polycystic ovary syndrome
por: Yang, Wan, et al.
Publicado: (2018)

Ovarian Response to Different Dose Levels of Follicle Stimulating Hormone (FSH) in Different Genotypes of Bangladeshi Cattle
por: Ali, M. S., et al.
Publicado: (2012)

SUN-239 A Case with Elevated Serum Follicle-Stimulating-Hormone (FSH) Concentrations Due to Macro-FSH
por: Hattori, Naoki, et al.
Publicado: (2019)

Onset and Heterogeneity of Responsiveness to FSH in Mouse Preantral Follicles in Culture
por: Hardy, Kate, et al.
Publicado: (2016)

Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women
por: Dumesic, Daniel A, et al.
Publicado: (2021)

Comparison of highly purified urinary versus recombinant FSH: Effect on ART outcomes in polycystic ovary syndrome
por: Sohrabvand, Farnaz, et al.
Publicado: (2012)

Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization
por: Figen Turkcapar, Ayse, et al.
Publicado: (2013)

Androgens improve ovarian follicle function impaired by glucocorticoids through an androgen-IGF1-FSH synergistic effect
por: Gao, Lingyun, et al.
Publicado: (2022)

Follicle Stimulating Hormone (FSH) as a Predictor of Decreased Oocyte Yield in Patients with Normal Anti-Müllerian Hormone (AMH) and Antral Follicle Count (AFC)
por: Miller, Colleen Marie, et al.
Publicado: (2023)

Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
por: Revelli, Alberto, et al.
Publicado: (2006)

Modulation of Cx43 and Gap Junctional Intercellular Communication by Androstenedione in Rat Polycystic Ovary and Granulosa Cells in vitro
por: Talhouk, Rabih, et al.
Publicado: (2012)

Abnormally Elevated Follicle-Stimulating Hormone (FSH) Level in an Infertile Woman
por: Catteau, Aurore, et al.
Publicado: (2019)

Effects of Adiponectin Including Reduction of Androstenedione Secretion and Ovarian Oxidative Stress Parameters In Vivo
por: Comim, Fabio V., et al.
Publicado: (2016)

Effects of Extra-Long-Acting Recombinant Bovine FSH (bscrFSH) on Cattle Superovulation
por: Gutiérrez-Reinoso, Miguel A., et al.
Publicado: (2022)

Follicle stimulating hormone modulates ovarian stem cells through alternately spliced receptor variant FSH-R3
por: Patel, Hiren, et al.
Publicado: (2013)

Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ERα in Mice
por: Lai, Luju, et al.
Publicado: (2018)

Ovarian volume is more closely related to the different manifestations of polycystic ovary syndrome than follicle number per ovary
por: Afrine, Shazia, et al.
Publicado: (2023)

Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation
por: Levi Setti, P. E., et al.
Publicado: (2014)

Androstenedione changes steroidogenic activity of SGBS cells
por: Ernst, Jana, et al.
Publicado: (2020)

Hormonal changes in consecutive clomiphene citrate stimulation cycles and their effect on pregnancy rates
por: Kovalak, Evrim Ebru, et al.
Publicado: (2022)

Antral follicle count and anti-Müllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation
por: Izhar, Rubina, et al.
Publicado: (2021)

Follicle-stimulating hormone (FSH) promotes retinol uptake and metabolism in the mouse ovary
por: Liu, Zhuo, et al.
Publicado: (2018)

Androgen potentiates the expression of FSH receptor and supports preantral follicle development in mice
por: Fujibe, Yuya, et al.
Publicado: (2019)

Corrigendum to “Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ERα in Mice”
por: Lai, Luju, et al.
Publicado: (2020)

Follicle-stimulating hormone (FSH) activates extracellular signal-regulated kinase phosphorylation independently of beta-arrestin- and dynamin-mediated FSH receptor internalization
por: Piketty, Vincent, et al.
Publicado: (2006)

The relationships of sex hormone‐binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome
por: Simons, Pomme I. H. G., et al.
Publicado: (2021)

Biotransformation of Phytosterols into Androstenedione—A Technological Prospecting Study
por: Nunes, Victor Oliveira, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mv5v0qii5uflp5e2hpoml5p2o6